This is a fresh batch of news and announcements from across Imperial.
from Appointment of Empire Experts to Prestigious Climate Change Commission, study Best treatment for lung volume reduction, hThere are some fast-reading news from across the university.
Appointment of the Climate Change Panel
Jim Ski, Professor of Sustainable Energy at Imperial’s Center for Environmental Policy, has been announced as the UK’s candidate to chair the Intergovernmental Panel on Climate Change (IPCC) 2023.
He is currently Co-Chair of IPCC Working Group III on Mitigation and co-led the IPCC’s flagship Special Report on Global Warming of 1.5°C. He has researched and authored or co-authored over 80 publications and several books on energy, climate change, and innovation.
If elected, Professor Scare outlined three key priorities for the IPCC. Promote the use of the best and most relevant science. Maximize the reach and impact of the IPCC’s work through engagement with policymakers and other stakeholders.
Professor Ski says: If elected, I would appreciate his 40+ years of scientific experience and expertise, unique international perspective, track record of building consensus, and unwavering commitment to understanding the impacts and challenges of climate change and ensuring that action is taken. Bring motivation to this role. Avoiding them is supported by sound science. ”
gates cambridge scholarship
An Imperial Engineering student has been selected as one of the recipients of this year’s prestigious International Graduate Scholarship.
Zimu Huo, a fourth year MEng in the Department of Biotechnology, has been selected as part of the 2023 cohort of the Gates Cambridge Scholarship Program from the University of Cambridge. The program was established in 2000 with a generous donation from the Bill and Melinda Gates Foundation. Since then, he has awarded 2,100 scholarships to scholars from 112 countries, representing more than 700 universities worldwide.
Zimu will use this scholarship to continue its research to improve healthcare accessibility around the world through the provision of cutting-edge and effective medical technology.
he said: This exciting technology has the potential to revolutionize our understanding of cardiovascular calcification formation and significantly improve our ability to diagnose and manage this condition. ”
Find out more about the Gates Cambridge Class of 2023 here.
Decisions about pulmonary therapy
Previous studies have shown that lung volume reduction surgery benefits emphysema patients by improving lung function, exercise capacity, and quality of life. However, questions remained about which of the two available treatments was more effective. A new study by Professors Nick Hopkinson and Sara Buttery finds that lung volume reduction surgery (LVRS) does not appear to be substantially superior to bronchoscopic lung volume reduction (BLVR). This helps people with emphysema make more informed decisions about the best treatment.
Whereas in LVRS the most damaged parts of the lung are removed and the healthier parts work better, in BLVR valves are placed in the airways to prevent air from reaching the damaged parts of the lungs. will be This will shrink the damaged area.
The trial found that LVRS did not produce superior results in individuals who were suitable for both treatments. This is important when educating patients about the procedure and guiding informed decision making. It provides details that are especially important for individuals making decisions between two procedures, such as length of stay, success rate, and complication rate. This is important to ensure that patients feel well-informed during the decision-making process.
Read the full European Respiratory Journal.
Want to know the latest news from Imperial? Sign up for Imperial Today, our free, ready-to-read daily electronic newsletter.